Cross-functional Collaboration is Key to Diagnostic Test Commercialization {White Paper}


With advances in molecular and genetic technologies and growing patient demand for more personalized laboratory developed tests (LDTs), the demand for such tests is booming. However, even with these favorable conditions, there are significant challenges in bringing new LDTs to market. With so many new tests being introduced, payers have a hard time wading through the noise to identify those that will be beneficial to their business and their patients.

To seize upon new business opportunities and meet market demands for new LDTs as well as take full advantage of the new rates for molecular and genetic lab tests, organizations that provide and develop diagnostic lab tests need strong cross-functional interaction between the revenue cycle and the lab. 


Download this white paper, and here is just some of what you will take away…

√  Understand the challenges in bringing new diagnostic tests to market

√  What questions to address during test development 

√  How collaborating with Quadax can help achieve your strategic objectives